Tag: oncology

1. Progression-free survival was longer in patients in the cabozantinib group (9.0 months) than in the sunitinib group (5.6 months). 2. Occurrence of grade 3 or 4 adverse events were similar among patients in the cabozantinib and sunitinib groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Papillary renal cell carcinoma (PRCC) is...
1. Low- and middle-income countries have a higher 30-day mortality in colorectal and gastric cancer surgeries compared with high-income countries. 2. Although the rate of peri-operative complications was similar across all country income levels, patients in low or lower-middle income countries were more likely to die from these events. Evidence Rating...